MIMH is assisting the St. Louis Planning Council with their annual needs assessment through web-based survey instruments for the newly insured and Veterans.
According to the National Institute of Mental Health, Bi-Polar Disorder is a brain disorder that causes unusual shifts in mood, energy, activity levels where day-to-day tasks become difficult. The symptoms can be severe and are more difficult to manage than normal than everyday highs and lows. If a person suffers from Bi-Polar Disorder poor job and/or school performance is often a problem. Other problems that can occur could be a change in energy levels, activities, sleep and behavior. Damaged relationships and even suicide are sometimes reported with this disorder. It is estimated that over 5 million American suffer from Bi-Polar Disorder.
If you work with clients who suffer from this debilitating disorder and/or you want to learn more, attending this workshop will help you understand how Bipolar Disorder manifests in behavior and effective treatment that can help clients.
METHOD of PRESENTATION
A case study review and video of a client diagnosed with Bi-Polar I
Discussion and additional illustrations will be presented.
During the program to following concepts are addressed:
Participants will come away with a better understanding of how Bi-polar disorder manifests in behavior and effective treatment that can help the client.
This study will examine cognitive function in HIV-infected women who abuse cocaine in addition to other substances, women that do not abuse cocaine but do abuse other substances, and a healthy control group. Results from the study will extend our understanding of the factors that affect cognition in HIV.
The specific aims are to determine if myasthenia gravis (MG) patients experience cognitive deficits compared to healthy control subjects, and to what extent cognitive difficulties in individuals with the disease may be due to disease activity, cognitive and physical fatigue, or psychiatric illness.
The DOTS (Drug Overdose Trust and Safety) project will “connect the dots” between overdose prevention and response initiatives across Missouri.
The purpose this study is to investigate central nervous system (CNS) injury among injection drug abusers co-infected with HIV and Hepatitis C (HCV). The study will incorporate biomarkers of hepatic disease, state-of-the-art neuroimaging methods, and neuropsychological outcomes.
Funded by the National Institute on Drug Abuse, this project produced a series of web-based video games designed to teach middle school students about the science of addiction.
This study will assess cardiovascular and neurocognitive functions, along with brain MRI to determine the effect of specific vascular disturbances on brain structure and function. It will also determine the effect of that such impairments have on CR outcome, quality of life, and longer-term health status of the elderly.
The major goal of this project is to examine the impact of methamphetamine abuse on the brain glutamine system utilizing MRS imaging.
This project will examine the efficacy of a compensatory strategy to support adherence to HIV treatment. The results will provide important insights regarding the clinical care of patients with HIV.
For the past several years, the MIMH has collaborated with the Missouri Department of Mental Health to help develop a website and associated videos to help Librarians across the state of Missouri learn to be sensitive to the needs of their customers who have intellectual and physical disabilities.
A video-rich website designed for women who are caring for their elderly family members.
MRPIC - Mental and Reproductive Health Fetal Alcohol Spectrum Disorder Practice Implementation Center focuses on training OBGYNs and Social Workers on identification, diagnosis, treatment and prevention of Fetal Alcohol Spectrum Disorders (FASD) via Screening, Intervention, Referral and Treatment (SBIRT).
Tony is a clinical psychologist who has specialised in autism spectrum disorders since he qualified as a clinical psychologist in England in 1975. He currently works in his own private practice, and is also adjunct professor at Griffith University, Queensland and senior consultant at the Minds and Hearts clinic in Brisbane. His book Asperger’s Syndrome – A Guide for Parents and Professionals has sold over 350,000 copies and has been translated into over 25 languages. His subsequent book, The Complete Guide to Asperger’s Syndrome, was published in October 2006 and is one of the primary textbooks on Asperger’s syndrome. He has several subsequent books published by Jessica Kingsley Publishers, Future Horizons Inc. and Guilford Press.
Tony has been invited to be a keynote speaker at many Australasian and International Conferences. He presents workshops and runs training courses for parents, professionals and individuals with Asperger's syndrome all over the world and is a prolific author of scientific papers and books on the subject.
He has worked with many thousands of individuals of all ages with Asperger's syndrome or an Autism Spectrum Disorder.
The Missouri HealthCare Homes (HCH) refers to a place where individuals can come throughout their lifetimes to have their healthcare needs identified and to receive the medical, behavioral and related social services and supports they need. HCH coordinates care in a way that recognizes all the needs of individuals. MIMH is currently the independent evaluator of the project.
MIMH, partnered with National Council on Alcoholism & Drug Abuse (NCADA), under the leadership of the Missouri Department of Mental Health, is implementing and evaluating a SAMHSA-funded 5-year, $5 million grant to reduce opioid overdose events in the Eastern Region of the state.
The Missouri Suicide Prevention Project (MSPP) is a joint suicide prevention project between the Missouri Department of Mental Health (DMH) and the MIMH. The MSPP primarily targets youth-serving organizations and at-risk youth and young adults ages 10 to 24. The MIMH is responsible for implementation and evaluation of the MSPP.
Bridgeway Behavioral Health contracted with the Missouri Institute of Mental Health to create a mobile application to support their adolescent substance abuse prevention program.
Implementing training and clinical practice of Screening, Brief Intervention, Referral and Treatment (SBIRT) for physicians, nurses, social workers, and other providers in general healthcare settings to address substance misuse and abuse.
International guidelines for antiretroviral therapy (ART) initiation in children with HIV/AIDS who are older than 12 months continue to recommend deferring therapy until symptomatic disease or immune compromise occurs, despite studies in younger infants (CHER trial) identifying a benefit for early treatment. This proposal will add robust neurodevelopmental and imaging outcomes to PREDICT.
Neuroimaging and Neurobehavioral Basis of Risky Decision Making in Adolescents
This project will develop neuroimaging biomarkers to assess the effects of risky decision making in HIV- and HIV+ adolescents.
Group comparisons and latent variable modeling will be conducted to examine relationships between the neuroimaging indices, genetic polymorphisms, and differences in cognitive function in older healthy adults. This study will be the first to integrate these approaches to examine a model of age-related cognitive decline implicating the subcortical white matter.
The goal of this project is to examine the neurovirulence of clade C HIV. The study utilizes diffusion tensor imaging, viral laboratory markers, and neuropsychological function to characterize the relevance of the Tat protein defect in clade C HIV.
Assess traumatic brain injuries and stress disorders in women who have experienced intimate partner violence in order to develop effective treatment
The SPIRIT project is a school-based substance abuse prevention program sponsored by the Missouri Department of Mental Health (DMH). The Missouri Institute of Mental Health (MIMH) conducts an annual process and outcome evaluation of the SPIRIT program.
MOSBIRT is a substance abuse prevention project that has screened more than 200,000 Missourians in various medical settings for risky substance use behaviors. Those at risk are offered 1 to 6 brief evidence based sessions to reduce those risks. With this early intervention, individuals can reduce their risks and improve their health.
The NeuroHIV Cure Consortium is a research collaboration that operates numerous neurological research studies related to acute HIV infection and cure strategies. The NeuroHIV Cure Consortium is primarily responsible for developing studies focused on HIV eradication and reservoirs in the central nervous system in partnership with these groundbreaking studies.
The goal of the project is to reduce the cost of emergency care, engage individuals with complicated challenges, and provide them with stabilizing evidenced-based interventions such as Motivational Interviewing and Critical Time Intervention.
This project assists nurses and clinicians in deciding the appropriate timing for initiating highly active antiretroviral therapy (HAART) and helps them evaluate the efficacy of tailored adjunctive neuroprotective therapies.
Using an experimental design, this study primes college students either to think about social interaction goals or about safety-related goals, and test the impact of the primed goal on implicit approach versus avoidance responses to alcohol images. It will also conduct psychometric analysis of four implicit approach-avoidance assessments.
The impacts of a physical trauma are well understood in the medical community, and treatment approaches have become quite advanced. Our ability to study the brain and its reactions to physical and chemical stimuli is relatively new, but growing at incredible speeds. "Traumatic Stress: New Mechanisms and Effective Treatment" will bring together a group of internationally recognized researchers to deliver a whole new perspective on what physically happens in the brain during and following traumatic stress. They will explore not only the physical, but the behavioral and emotional reactions to traumatic stress through the lens of groundbreaking new research. Most importantly, they will offer a fresh perspective on care and treatment. This conference will change how you look at traumatic stress in the brain and what to do about it.